BETHESDA, Md., June 27, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...
BETHESDA, Md., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (GANX),, a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results